Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis

In a context of rising cancer drug costs, this research explores a low-cost treatment to optimize breast cancer preventive intervention. The approach is safe and based on repurposed drugs that could enhance prevention strategies for obesity- and insulin-related cancers, offering immediate applicability to a large-scale trial in women at risk.

Authors

Institutions

Publication Details

Journal
Cancer Prevention Research
Published
2025-10-29
DOI
https://doi.org/10.1158/1940-6207.capr-25-0104
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis

Oriana Pala, Nicoletta G. Gandolfo, Sara Gandini, Davide Serrano et al.
Cancer Prevention Research
Cancer Risks and Factors
article

Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis

Oriana Pala, Nicoletta G. Gandolfo, Sara Gandini, Davide Serrano, Marina Gualco, Matteo Lazzeroni, Brandy M. Heckman‐Stoddard, Eileen Dimond, M.C. García Lozano, Saverio Minucci, Stefano Spinaci, Flavio Guasone, Stefania Uncini, Mariangela Rutigliani, Chiara Arianna Accornero, Mauro D’Amico, Edward R. Sauter, Tania Buttiron Webber, Harriet Johansson, Eduardo Vilar, Emma Firpo, Irene Maria Briata, Aliana Guerrieri‐Gonzaga, Andrea DeCensi, Martino Oliva, Bernardo Bonanni, Lana A. Vornik, Mattia Intra, Parijatham S. Thomas, Andrea Rattaro, Monica Peresi, Araceli García-González, Paolo Veronesi
article en

Abstract

In a context of rising cancer drug costs, this research explores a low-cost treatment to optimize breast cancer preventive intervention. The approach is safe and based on repurposed drugs that could enhance prevention strategies for obesity- and insulin-related cancers, offering immediate applicability to a large-scale trial in women at risk.

Cancer Prevention ResearchVol. 19(1)
Champalimaud Foundation (PT), National Institutes of Health (US), The University of Texas MD Anderson Cancer Center (US), Ente Ospedaliero Ospedali Galliera (IT), National Cancer Institute (US), Villa Torri Hospital (IT), European Institute of Oncology (IT)
Ministero della Salute, Rising Tide Foundation, University of Texas MD Anderson Cancer Center, National Cancer Institute, Janssen Research and Development
Openalex Percentile: Top 58%
Cancer Risks and Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.